Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer (Q37144740)

18 August 2017

1 reference

title

Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer (English)

1 reference

lip and oral cavity carcinoma

18 August 2017

1 reference

7

Alessandra Rinaldo

1 reference

18 August 2017

8

Alfio Ferlito

1 reference

18 August 2017

6

Robert P Takes

1 reference

18 August 2017

1

Hiroyuki Hamakawa

1 reference

18 August 2017

Koh-Ichi Nakashiro

2

1 reference

18 August 2017

Tomoki Sumida

series ordinal

3

1 reference

18 August 2017

Satoru Shintani

series ordinal

4

1 reference

18 August 2017

Jeffrey N Myers

series ordinal

5

1 reference

18 August 2017

language of work or name

1 reference

1 June 2008

1 reference

18 August 2017

1 reference

18 August 2017

30

1 reference

18 August 2017

6

1 reference

18 August 2017

800-809

1 reference

Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells

18 August 2017

1 reference

Constitutive overexpression of cyclin D1 in human breast epithelial cells does not prevent G1 arrest induced by deprivation of epidermal growth factor.

21 January 2018

1 reference

7 January 2021

Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin

1 reference

7 January 2021

Gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, up-regulates p27KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines

1 reference

7 January 2021

Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells

1 reference

7 January 2021

A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase

1 reference

7 January 2021

Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation

1 reference

7 January 2021

Lymph node metastasis of oral cancer visualized in live tissue by green fluorescent protein expression

1 reference

7 January 2021

Gefitinib ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells

1 reference

7 January 2021

Integrins alpha5beta1, alphavbeta1, and alphavbeta6 collaborate in squamous carcinoma cell spreading and migration on fibronectin

1 reference

7 January 2021

Expression of the alphavbeta6 integrin promotes migration and invasion in squamous carcinoma cells.

1 reference

7 January 2021

Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly

1 reference

7 January 2021

Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation

1 reference

7 January 2021

ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer

1 reference

7 January 2021

Enhancement of tumor radioresponse by combined treatment with gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancer

1 reference

7 January 2021

Overexpression of cyclooxygenase-2 is associated with radioresistance in oral squamous cell carcinoma

1 reference

7 January 2021

Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

1 reference

7 January 2021

Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor

1 reference

7 January 2021

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

7 January 2021

The organization, promoter analysis, and expression of the human PPARgamma gene

1 reference

7 January 2021

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

1 reference

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

7 January 2021

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

1 reference

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

7 January 2021

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

1 reference

7 January 2021

Terminal differentiation of human breast cancer through PPAR gamma.

1 reference

7 January 2021

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1 reference

7 January 2021

Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis

1 reference

7 January 2021

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

7 January 2021

Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists

1 reference

7 January 2021

Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death

1 reference

7 January 2021

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

1 reference

7 January 2021

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

1 reference

7 January 2021

Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators

1 reference

7 January 2021

Thiazolidinediones inhibit cell growth of human oral squamous cell carcinoma in vitro independent of peroxisome proliferator-activated receptor gamma

1 reference

7 January 2021

15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells

1 reference

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

1 reference

7 January 2021

Progestin regulation of cellular proliferation

1 reference

7 January 2021

Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation

1 reference

7 January 2021

Mechanisms of hormone resistance in breast cancer

1 reference

7 January 2021

Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma

1 reference

7 January 2021

Intraoral minor salivary gland tumors: a clinicopathological study of 82 cases

1 reference

7 January 2021

Estrogen and progesterone receptors in salivary gland adenoid cystic carcinoma.

1 reference

7 January 2021

Steroid hormone receptors in parotid gland cystadenolymphoma (Warthin's tumour).

1 reference

7 January 2021

Immunohistochemical localization of estradiol, progesterone, and progesterone receptor in human salivary glands and salivary adenoid cystic carcinomas

1 reference

7 January 2021

Coactivator-mediated estrogen response in human squamous cell carcinoma lines

1 reference

7 January 2021

Steroid hormone receptors and long term survival in invasive ovarian cancer

1 reference

7 January 2021

Cytosol estrogen and progestin receptors in endometrial carcinoma of patients treated with surgery, radiotherapy, and progestin. Clinical correlates

1 reference

7 January 2021

Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1).

1 reference

7 January 2021

Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins

1 reference

7 January 2021

Growth inhibition of human salivary gland tumor cells by introduction of progesterone (Pg) receptor and Pg treatment

1 reference

7 January 2021

Biological role of estrogen receptor beta in salivary gland adenocarcinoma cells

1 reference

7 January 2021

A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland.

1 reference

7 January 2021

Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets

1 reference

7 January 2021

Immunohistochemical evaluation of estrogen and progesterone receptors in adenoid cystic carcinoma of salivary gland origin

1 reference

7 January 2021

Immunohistochemical detection of oestrogen and progesterone receptors in salivary tumours

1 reference

7 January 2021

Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases

1 reference

7 January 2021

Induction of differentiation in maxillary adenoid cystic carcinomas by adoptive immunotherapy in combination with chemoradiotherapy.

1 reference

7 January 2021

Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.20830

1 reference

18 August 2017

1 reference